Celltrion, Inc.

About Celltrion, Inc.

Celltrion, Inc. is a leading biopharmaceutical company based in the UK, dedicated to the development and manufacturing of innovative therapies for various diseases. Established with a vision to enhance global health, Celltrion focuses on creating high-quality biosimilars and monoclonal antibodies that are both effective and affordable.

The company operates state-of-the-art facilities equipped with advanced technology, ensuring compliance with international standards. Celltrion’s research and development team comprises highly skilled professionals who are committed to scientific excellence and innovation.

With a strong emphasis on patient-centric solutions, Celltrion aims to address unmet medical needs through its diverse product portfolio. The company collaborates with healthcare professionals and institutions worldwide to bring its therapies to market efficiently.

Celltrion is also actively involved in clinical trials, contributing to the advancement of medical science and the discovery of new treatment options. The company’s commitment to sustainability and ethical practices is reflected in its operations and corporate social responsibility initiatives.

• Core Activities: Development of biosimilars and monoclonal antibodies.
• Vision: To enhance global health through innovative therapies.
• Commitment: Patient-centric solutions and scientific excellence.

As a forward-thinking organization, Celltrion continues to invest in research and development, aiming to expand its reach and impact in the biopharmaceutical industry. The company’s dedication to quality and innovation positions it as a trusted partner in healthcare.